Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Boeing

3 Companies People Hate That You Should Buy

There's no need to worry about this business even if we head into a recessionary or high-inflation environment.

Altria Shows Once Again Why Tobacco Is a Great Defensive Stock

Altria reported solid Q1 2022 results, with continuing earnings stability despite inflation, higher oil prices, and other macro pressures. Adjusted EPS grew 4.7% year-on-year, driven by growth in the core Smokeables segment and helped by share repurchases.

Altria: Stable Q1 Even As Macro Worsened; 6.6% Dividend Yield

British American Tobacco

Philip Morris

Tobacco stocks are rising today but investors should be wary of the pending ban on menthol products from Capitol Hill. Here's what to know.

Tobacco Stocks News: Why Are MO, PM, BTI Stocks in the Spotlight Today?

Altria Group's (MO) first-quarter 2022 results reflect increased revenues and earnings. Pricing remains an upside, though shipment volumes appear soft.

Altria (MO) Q1 Earnings & Revenues Top Estimates, Pricing Aids

Altria Group, Inc. (NYSE:MO ) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Mac Livingston - VP, IR, Altria Client Services Billy Gifford - CEO Sal Mancuso - EVP and CFO Conference Call Participants Chris Growe - Stifel Vivien Azer - Cowen and Company Pamela Kaufman - Morgan Stanley Gaurav Jain - Barclays Bonnie Herzog - Goldman Sachs Priya Ohri-Gupta - Barclays Jennifer Maloney - The Wall Street Journal Operator Good day, and welcome to the Altria Group 2022 First Quarter Earnings Conference Call. Today's call is scheduled to last about an hour, including remarks by Altria's management and a question-and-answer session.

Altria Group, Inc. (MO) CEO Billy Gifford on Q1 2022 Results - Earnings Call Transcript

Altria is far from a dividend trap. Stock is not overvalued despite a 15% YTD increase.

Altria Earnings: Far From A Dividend Trap

Altria (MO) delivered earnings and revenue surprises of 2.75% and 0.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Q1 Earnings and Revenues Surpass Estimates

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA REPORTS 2022 FIRST-QUARTER RESULTS; REAFFIRMS 2022 FULL-YEAR EARNINGS GUIDANCE

CORRECTING and REPLACING...Altria Reports 2022 First-Quarter Results; Reaffirms 2022 Full-Year Earnings Guidance

The cigarette and tobacco manufacturer is still unable to sell IQOS but maintains full-year earnings guidance.

Altria Tops Earnings Estimates Despite Slight Revenue Dip

Altria Inc. shares MO, +0.07% rose slightly premarket after the parent of tobacco company Philip Morris USA beat profit estimates for the first quarter but revenue fell slightly short. The company posted net income of $1.959 billion, or $1.08 a share, for the quarter, up from $1.424 billion, or 77 cents a share, in the year-earlier period.

Altria beats profit estimates for the first quarter as revenue falls slightly short

AbbVie

Black Hills

Federal Realty Investment Trust

Kimberly-Clark

Coca-Cola

Northwest Natural Gas

At 24/7 Wall St., we know how important dividend size, stability and growth are to growth and income investors who need a dependable stream of income.

7 ‘Strong Buy' Dividend Kings to Move to Fast in Case of Total Market Meltdown

Altria Reports 2022 First-Quarter Results; Reaffirms 2022 Full-Year Earnings Guidance

Altria stock yields 6.6% and has a history of dividend growth. The company has also grown operating income - what's the issue?

Altria: Avoid This Dividend Value Trap

Given the headlines about inflation, stocks of companies with pricing power are likely to have risen accordingly, and the search for a hedge against inflation seems futile. While this is certainly true of many companies, Altria's stock is still a compelling value - even at $55 per share.

Altria Remains A Favorably Valued Inflation Hedge

Altria Group's (MO) first-quarter results are likely to reflect gains from pricing and oral tobacco products, while cigarette volumes are likely to have been soft.

What's in the Offing for Altria Group (MO) in Q1 Earnings?

Las Vegas Sands

Sirius XM Holdings Inc

Before markets opened on Tuesday, United Parcel Service beat analysts' profit and revenue estimates for the March quarter.

Earnings Previews: Altria, Las Vegas Sands, Sirius XM

Diageo

General Dynamics

Lockheed Martin

Constellation Brands

Molson Coors Brewing

Vici Properties

We have seen four down weeks in a row, and the odds are things could get worse for the stock market, despite Monday's big upside reversal.

7 Big Dividend-Paying Sin Stocks That Can Survive a Potential Upcoming Market Crash

Dow Inc

LyondellBasell Industries

Verizon

Over the past decade, GuruFocus' Most Broadly Held Portfolio, a model portfolio consisting of the 25 stocks that appear in the highest number of guru portfolios, has outperformed the S&P 500 with an annualized return of 15.61% versus the benchmark's 12.28%.

5 High Dividend Yield Stocks Gurus Are Buying

Apple

Equinor

Pfizer

AT&T

Target

Freeport-McMoRan

Undervalued large-cap stocks with a low-beta and attractive dividend yield. Undervalued stocks to buy with recession and inflation headwinds.

7 Undervalued Large-Cap Stocks to Buy Now

Eagle Bulk Shipping

OGE Energy

What's fueling this surge among higher-income stocks?

25 Dividend Stocks To Buy High, Sell Higher

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA TO HOST WEBCAST OF 2022 FIRST-QUARTER RESULTS

Altria to Host Webcast of 2022 First-Quarter Results

Dollar Tree

Mondelez

Nutrien

UnitedHealth Group

Exxon Mobil

Consider buying these seven inflation resistant stocks, even as the market is hopeful that the inflation rate has peaked. The post 7 Inflation Resistant Stocks to Buy Now appeared first on InvestorPlace.

7 Inflation Resistant Stocks to Buy Now

Altria has raised its dividend 56 times in the last 52 years. Altria results for 2021 were encouraging.

Is Altria Stock Undervalued Or Overvalued?

Cummins

Stanley Black & Decker

Whirlpool

In this article, I'm doing a bit of a follow-up of my recent article where I went through 6 German companies I'm currently buying.

5 NA Dividend Stocks With Over 15% Upside And Good Yield

News for Altria Stock (MO)